生長停滯特異性蛋白6(GAS6)活性蛋白
Active Growth Arrest Specific Protein 6 (GAS6)
AXLLG; AXSF; AXL Stimulatory Factor; AXL receptor tyrosine kinase ligand
- 編號APA204Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
- 性狀凍干粉
- 純度> 90%
- 等電點5.6
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1766 ¥ 4416 ¥ 8832 ¥ 26496 ¥ 66240
- 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實驗
Growth arrest-specific 6, also known as?GAS6, is a?gamma-carboxyglutamic acid (Gla) domain-containing protein thought to be involved in the stimulation of cell proliferation. It has been reported that both PC-3 and DU 145 human prostate cancer cell lines are stimulated to proliferate by Gas6, however, this proliferative response strictly correlates with the expression of the Axl receptor, being higher in DU 145 cells. To test the proliferative effect of Gas6, DU 145 cells were seeded into triplicate wells of 96-well plates at a density of 2,000 cells/well and allowed to attach overnight, then the medium was replaced with serum-free standard DMEM prior to the addition of various concentrations of GAS6. After incubated for 72h, cells were observed by inverted microscope and cell proliferation was measured by Cell Counting Kit-8 (CCK-8). Briefly, 10μL of CCK-8 solution was added to each well of the plate, then measure the absorbance at 450nm using a microplate reader after incubating the plate for 1-4 hours at 37oC.
Cell proliferation of DU145 cells after incubation with GAS6 for 72h observed by inverted microscope was shown in Figure 1.
The dose-effect curve of GAS6 was shown in Figure 2. It was obvious that GAS6 significantly promoted cell proliferation of DU145 cells. The ED50 for this effect is typically 0.77~38.08ng/mL.
用法
Reconstitute in 20mM Tris, 150mM NaCl (PH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APA204Hu01 | 生長停滯特異性蛋白6(GAS6)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA204Hu01 | 生長停滯特異性蛋白6(GAS6)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA204Hu03 | 生長停滯特異性蛋白6(GAS6)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA204Hu02 | 生長停滯特異性蛋白6(GAS6)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA204Hu02 | 生長停滯特異性蛋白6(GAS6)多克隆抗體 | WB; IHC; ICC; IP. |
PAA204Hu03 | 生長停滯特異性蛋白6(GAS6)多克隆抗體 | WB; IHC; ICC; IP. |
PAA204Hu01 | 生長停滯特異性蛋白6(GAS6)多克隆抗體 | WB; IHC; ICC; IP. |
LAA204Hu71 | 生長停滯特異性蛋白6(GAS6)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAA204Hu22 | 生長停滯特異性蛋白6(GAS6)單克隆抗體 | WB; IHC; ICC; IP. |
SEA204Hu | 生長停滯特異性蛋白6(GAS6)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA204Hu | 生長停滯特異性蛋白6(GAS6)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
Acta Pharmacol Sin. | Pharmacological evidence: a new therapeutic approach to the treatment of chronic heart failure through SUR2B/Kir6.1 channel in endothelial cells. [pubmed:27890915] |
Frontiers of Medicine | The effects of Parenteral K1 administration in Pseudoxanthoma elasticum Patients Versus controls. a Pilot study [Pubmed:29713628] |
Oncotarget | DAPK and CIP2A are involved in GAS6/AXL-mediated Schwann cell proliferation in a rat model of bilateral cavernous nerve injury [Pubmed:29464081] |
journal of nutritional biochemistry | Gamma-glutamyl carboxylated Gas6 mediates the beneficial effect of vitamin K on lowering hyperlipidemia via regulating the AMPK/SREBP1/PPARα signaling?… [Pubmed: 31226525] |
CELL DEATH AND DIFFERENTIATION | KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway [Pubmed: 33139930] |
重度子癇前期患者血清GAS6 與其他炎癥因子的相關(guān)性研究 [] | |
JOURNAL OF NUTRITIONAL BIOCHEMISTRY | Gamma-glutamyl carboxylated Gas6 facilitates the prophylactic effect of vitamin K in inhibiting hyperlipidemia-associated inflammatory pathophysiology via arresting MCP-1/ICAM-1 mediated monocyte-hepatocyte adhesion [33789149] |